I very much agree that unprofessional submissions would be counterproductive. My personal view is that one or two very high quality submissions from HC people might be useful. However, I think large numbers that add nothing could have a quite negative effect.
I think anyone considering lodging a submission should seriously consider some questions first:
* Can you add anything useful, or will any important decision makers feel like they have wasted their valuable time by reading your submission?
* What about you means your view is relevant to AdComm/FDA decision processes? Eg. Have you or a loved one suffered from GVHD? Are you a doctor who treats GVHD? Are you part of a patient advocacy group? Are you a research scientist or a stem cell expert? Are you an American resident or citizen (AdComm/FDA are answerable to the American public, not random Aussies)?
I very much agree that unprofessional submissions would be...
-
- There are more pages in this discussion • 590 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |